Physician profile
Denise Ythier
NPI 1023018702
$2,572.46
in general payments reported to CMS, 2019-2025
16 companies · $371 in 2025
The $371 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $821 · 2022: $858 · 2023: $367 · 2024: $156 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $844 · Education: $48.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $844.34 |
| Education | $48.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $640.03 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $411.52 | 2021-2024 | Trulance |
| Takeda Pharmaceuticals U.S.A., INC. | $390.95 | 2021-2025 | Entyvio, Livtencity, Gattex |
| Janssen Biotech, INC. | $273.08 | 2022-2023 | Stelara, Tremfya |
| Gilead Sciences, INC. | $191.93 | 2021 | |
| Celgene Corporation | $191.60 | 2022-2023 | Zeposia |
| E.R. Squibb & Sons, L.L.C. | $132.75 | 2023 | Zeposia |
| Intercept Pharmaceuticals, INC. | $121.99 | 2021 | |
| Genzyme Corporation | $39.74 | 2022-2023 | |
| Nestle Healthcare Nutrition INC. | $39.54 | 2021 | |
| Ferring Pharmaceuticals INC. | $34.44 | 2023 | Rebyota |
| Ironwood Pharmaceuticals, INC | $30.29 | 2021-2022 | |
| Madrigal Pharmaceuticals | $21.06 | 2025 | Rezdiffra |
| Ardelyx, INC. | $20.91 | 2025 | Ibsrela |
| Alnylam Pharmaceuticals INC. | $17.40 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.23 | 2023 | Avsola, Amjevita |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Ythier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.